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Abstract
Background This study aimed to identify (1) if the
postoperative increase in the neutrophil-to-lymphocyte
ratio (NLR) is different between contrasting knee arthro-
plasty procedures, and (2) if the NLR predicts venous
thromboembolism (VTE) after total knee arthroplasty
(TKA).
Materials and methods To address the first objective, we
retrospectively studied patients who underwent primary
unilateral TKA (n = 111) or unicompartmental knee
arthroplasty (UKA; n = 74) between 2009 and 2012.
Patients who required a blood transfusion, underwent
autologous blood salvage, experienced any postoperative
complication (such as VTE), or were re-admitted[90 days
were excluded from analysis. For the second objective, we
retrospectively identified patients (cases, n = 10) who
underwent primary unilateral TKA between 2010 and 2012
and developed postoperative VTE (deep venous thrombo-
sis, pulmonary embolism, or both) during inpatient care
(postoperative day 1 or day 2). Cases were matched to
surgeon, gender, body mass index, age, and date of surgery
controls (n = 20) who underwent primary unilateral TKA
without developing VTE before patient discharge. The
NLR was calculated from the neutrophil and lymphocyte
counts extracted from pre- and postoperative (day 1 and
day 2) blood chemistry records.
Results On postoperative day 1, the NLR increase was
exacerbated (p = 0.02) following TKA compared to UKA
and predicted (p = 0.02) the occurrence of VTE in TKA
patients prior to hospital discharge.
Conclusion We conclude that the NLR increase is greater
following TKA compared to UKA and could serve as a
matrix to predict or identify a patient susceptible of sus-
taining VTE after TKA.
Level of evidence 3.
Keywords Total knee arthroplasty  Unicompartmental
knee arthroplasty  Neutrophil  Lymphocyte  Venous
thromboembolic event
Introduction
Osteoarthritis (OA) is the most common degenerative joint
disease [1] and the knee is one of themost commonly affected
sites. Total knee arthroplasty (TKA) is a safe and effective
surgery for treating knee OA, and it is estimated that the
number of knee arthroplasty procedures performed annually
in the United States will reach 3.5 million by the year 2030
[2]. Although infrequent (*1–3 %), venous thromboem-
bolism (VTE) (including deep venous thromboembolism
[DVT], pulmonary embolism [PE], or both) is a life-threat-
ening complication that can occur after TKA [3–6]. Over the
past two decades, unicompartmental knee arthroplasty
(UKA) has emerged as a less invasive alternative to TKA
when knee OA is limited to a single compartment. In com-
parison to TKA, the prevalence of postoperative VTE
(*0.1 %) is apparently lower after UKA [4, 7, 8].
In other pathological conditions, the neutrophil-to-lym-
phocyte ratio (NLR) is developing as a clinical tool that
accurately predicts VTE [9–14]. The NLR is a ratio
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between the absolute neutrophil and lymphocyte counts,
and therefore, is a marker of systemic inflammation rep-
resentative of innate and adaptive immunity. Although
systemic inflammation modulates the coagulation process
[15], it is surprisingly unknown if the NLR is different
between knee arthroplasty procedures with contrasting risk
levels of sustaining VTE, and more importantly, if the NLR
predicts VTE after TKA. Therefore, the purpose of this
study was two-fold. The first objective was to identify if the
NLR is different between arthroplasty procedures that
commonly treat knee OA but possess contrasting risk levels
of sustaining VTE. The second objective was to identify if
the NLR predicts VTE after TKA. We hypothesized that
the NLR increase is greater following TKA compared to
that after UKA and that the NLR predicts VTE after TKA.
We performed two retrospective studies to test our
hypothesis. In the first study, we compared the NLR
between two knee arthroplasty modalities—total and uni-
compartmental. The second study consisted of a retro-
spective case–control design and investigated the
predictability of the NLR on VTE after TKA.
Materials and methods
To test our hypothesis, we performed two studies that
were approved by an Institutional Review Board (Central
Region, Intermountain Healthcare, Salt Lake City, UT).
The studies were performed in accordance with the ethical
standards as laid down in the 1964 Declaration of Helsinki
and its later amendments or comparable ethical standards.
In Study 1, we retrospectively reviewed the medical
charts of 472 patients who underwent elective primary
unilateral TKA (n = 302) or UKA (n = 170) from January
2009 to December 2012 by one orthopedic surgeon at a
single institution (The Orthopedic Specialty Hospital,
Murray, UT). Patients were identified using the International
Classification of Diseases 9th revision, and all patients were
diagnosed with knee OA from X-ray images and voluntarily
elected for knee arthroplasty. Demographic and surgery
variables were recorded for each patient. Patients were
excluded from analysis if they underwent bilateral proce-
dures, were re-admitted within 90 days of surgery, had pre-
or postoperative infection, had DVT or PE, or received a
blood transfusion, manipulation, or autologous blood sal-
vage. Patients were also excluded from analysis if they were
lacking an American Society of Anesthesiologists (ASA)
score, or the pain and Knee Outcome Survey scores were not
documented at physical therapy.
Following screening, 111 TKA (Zimmer Total Knee;
Zimmer, Inc., Warsaw, IN, USA) and 74 UKA (Oxford
Partial Knee; Biomet Orthopedics, Warsaw, IN, USA)
patients were included in the final analysis. Patients who
underwent UKA displayed isolated anteromedial compart-
ment degeneration, a well-preserved lateral compartment, no
greater than mild patellofemoral degenerative changes, and
an intact anterior cruciate ligament. TKA was performed in
patients who did not satisfy the criteria for UKA as deter-
mined by one orthopedic surgeon. Tolerable pain levels,
normal venous blood O2 and blood count, and no signs of PE
were required before inpatient discharge after surgery.
In Study 2, we retrospectively identified patients (cases)
who underwent elective primary unilateral TKA at a single
facility (The Orthopedic Specialty Hospital, Murray, UT)
and developed postoperative VTE (i.e., DVT, PE, or both)
during inpatient care. Patients who underwent elective
primary unilateral TKA without developing VTE during
inpatient care served as controls. Cases were identified
using the Agency for Healthcare Research and Quality
Patient Safety Indicator 12 criteria [16], and the Interna-
tional Classification of Diseases 9th revision. The presence
or absence of VTE was confirmed in each patient’s dis-
charge notes. In all cases, DVTs were identified using
ultrasound and PEs were identified by chest computed
tomography angiogram. Ultrasound and chest computed
tomography angiograms were not performed in asymp-
tomatic patients who were identified as controls.
To minimize the variability in surgical procedures,
components, and perioperative treatments, data extraction
was limited from January 1, 2010 to the end of December
2012. During this period, eleven patients (from 1,339 pri-
mary unilateral TKAs; 0.82 %) were identified as experi-
encing postoperative (day 1 or day 2) VTE. Cases were
matched to surgeon, gender, body mass index (BMI), and
age controls (two controls for every case). Each case was
matched to asymptomatic patients who underwent surgery
by the same surgeon and were of the same gender, age, and
BMI. Investigators responsible for matching were blinded to
blood chemistry results. We were unable to identify controls
for one case with an exceptionally high BMI (46.7 kg/m2),
and therefore, this case was excluded from data analysis.
The final analysis consisted of twenty controls and ten cases
(DVT, n = 5; PE, n = 4; DVT and PE, n = 1).
Cases were further identified as having a history of
diabetes (n = 2), heart problems (e.g., previous heart
attack, irregular heartbeat, angina, heart failure; n = 1),
previous blood clot, transfusion or bleeding tendency
(n = 1), or cancer (n = 2). Controls had a history of dia-
betes (n = 4), heart problems (n = 10), previous blood
clot, transfusion or bleeding tendency (n = 5), stroke
(n = 1), multiple sclerosis (n = 1), or cancer (n = 2).
Controls contained two former and one current smoker,
while none of the cases reported a previous or current
smoking habit.
The ASA physical status classification score was
recorded for each subject. Five subjects (two cases and
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three controls) received 4–8 mg of dexamethasone before
induction of anesthesia. The exclusion of these patients
from the statistical analysis did not change the significance
of the NLR between groups, and therefore, were included
in the final analysis.
All patients were treated with compression stockings
from the time of surgery as well as a prophylactic antico-
agulant. Ten cases and sixteen controls were titrated with
5 mg of Coumadin (Bristol-Myers Squibb, New York,
NY, USA) in order to achieve an INR target of 1.5–2.0.
Two controls were treated with Xarelto (Leverkusen,
Germany) (monitored by anticoagulation monitoring
clinic) and two controls with Arixtra (GlaxoSmithKline,
Research Triangle Park, NC, USA) (2.5 mg subcuta-
neously). Five cases were administered Lovenox (Sanofi-
Aventis, Bridgewater, NJ, USA) when their INR values
were\2.0.
For the TKA groups in Study 1 and Study 2, preopera-
tive (morning of surgery and following a 10-h fast) and
postoperative (day 1 and day 2; the morning after surgery
and following a 10-h fast during inpatient care) blood
chemistries were performed at a hospital laboratory (blin-
ded) and results were extracted from an electronic database
warehouse. For the UKA group in Study 1, blood che-
mistries were performed preoperative (morning of surgery
and following a 10-h fast) and on day 1 (the morning after
surgery and following a 10-h fast during inpatient care).
Blood chemistries for the UKA group in Study 1 were
limited to postoperative day 1 since a postoperative blood
draw on day 2 is not a standard of care procedure for the
participating surgeon. The NLR was calculated from the
absolute neutrophil and lymphocyte counts.
Data were checked for normality prior to all statistical
analyses with the Shapiro–Wilk test. To test the hypothesis
for Study 1, and because the data were not normally dis-
tributed, we performed a Friedman two-way analysis of
variance test followed by multiple pairwise comparisons
when appropriate to determine if the NLR was different
between TKA and UKA patients prior to and following
surgery. Likewise, separate Friedman two-way analysis of
variance tests followed by multiple pairwise comparisons
when appropriate were performed to determine if the
neutrophil and lymphocyte counts were different between
TKA and UKA patients prior to and following surgery. To
test the hypothesis for Study 2, we performed univariate
logistic regression to determine if the NLR on day 1 pre-
dicted VTE on day 1 and day 2 post TKA. Separate
repeated measures analysis of variance followed by Bon-
ferroni corrections on multiple pairwise comparisons was
performed when appropriate on other repeated measure
variables for Study 2. The statistical significance of subject
characteristics was assessed with separate t tests for Study
1 and Study 2. The length of stay and ASA score were
assessed with separate Pearson chi-squared tests. All sta-
tistical analyses were performed with SYSTAT (version
13.1, Chicago, IL USA). Data are presented as mean (SD)
unless noted otherwise.
Results
Study 1. Blood chemistries and subject characteristics
(with the exception of height, p = 0.002) were not sig-
nificantly different (p range 0.07–0.90) between TKA and
UKA patients prior to surgery (Table 1). As expected,
tourniquet duration during surgery was significantly
(p\ 0.001) increased in TKA (69.0 [9.2] min) compared
to UKA group [57.8 [5.2] min). Following surgery, neu-
trophil counts were significantly increased in both groups
(p\ 0.001, Fig. 1a). However, neutrophil counts were not
significantly (p = 1.00) different between arthroplasty
procedures. Conversely, the lymphocyte decrease
(p = 0.001, Fig. 1b) and NLR increase (p = 0.02, Fig. 1c)
were more prominent following TKA compared to after
UKA.
Study 2. Subject characteristics, length of stay, and
blood chemistries prior to surgery were not significantly
(p range = 0.25–0.78) different between groups (Table 2).
On postoperative day 1, there was a significant increase in
neutrophil (p = 0.008, Fig. 2a) and a significant decrease
in lymphocyte (p = 0.008, Fig. 2c) counts in the cases and
controls. However, neutrophil (p = 0.22) and lymphocyte
(p = 0.32) counts were not significantly different between
groups. In contrast, the increase in the NLR was
Table 1 Study 1 subject characteristics and results
TKA UKA P value
No. (female: male) 111 (80:31) 74 (30:44)
Age (years) 62 (9) 62 (9) 0.90
Height (cm) 169 (10) 173 (10) 0.002
Body mass (kg) 98.0 (24.7) 95.9 (18.6) 0.80
BMI (kg/m2) 34.4 (7.8) 32.1 (5.7) 0.07
ASA score 2.41 (0.58) 2.35 (0.67) 0.34
1 (n) 5 7
2 (n) 56 35
3 (n) 50 31
4 (n) 0 1
Length of stay (days) 2.88 (0.44) 1.22 (0.48) \0.001
0 (n) 0 1
1 (n) 2 57
2 (n) 12 15
3 (n) 94 1
4 (n) 3 0
Data are presented as mean (SD) unless noted otherwise
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significantly (p = 0.002) more pronounced in cases com-
pared to controls on day 1 (Fig. 2c).
Consistent with our hypothesis, the NLR on day 1 pre-
dicted the occurrence of VTE after TKA and during
inpatient care (p = 0.02; odds ratio (OR) 1.38; 95 %
confidence interval (CI) 1.05–1.80). We performed a sec-
ondary analysis excluding day 1 event cases (n = 4) and
their controls (n = 8) to confirm that a preceding NLR
predicts a subsequent VTE after knee arthroplasty. Sup-
porting the earlier finding, the NLR on day 1 predicted
VTE on day 2 (p = 0.04; OR 1.44; 95 % CI 1.01–2.05).
Discussion
Knee arthroplasty is an independent risk factor for devel-
oping VTE [17–19]. Revealing a matrix from a routine
blood chemistry performed prior to and following knee
arthroplasty could impact the physician’s decision process,
improve patient care, and further minimize the risk of
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Fig. 1 Blood cell counts and NLR prior to (Pre) and one day
following (1-d) TKA and UKA. a Neutrophil counts were signifi-
cantly (bar, p\ 0.001 vs Pre) increased following TKA and UKA.
The neutrophil increase was not significantly (p = 1.00) different
between TKA and UKA on 1-d. b Lymphocyte counts were
significantly decreased following TKA (*p\ 0.01 vs Pre) and UKA
(*p\ 0.01 vs Pre). The lymphocyte decrease was significantly more
pronounced ($p = 0.001) following TKA compared to that after
UKA. c The NLRs were significantly increased following TKA
(*p\ 0.001 vs Pre) and UKA (*p\ 0.001 vs Pre). The NLR increase
was significantly ($p = 0.02) more pronounced after TKA compared
to UKA. Data are presented as mean (SD)
Table 2 Study 2 subject characteristics and results
Cases Controls P value
No. (female male) 10 (7:3) 20 (14:6)
Age (years) 65 (5) 64 (7) 0.78
Height (cm) 169 (9) 168 (12) 0.74
Body mass (kg) 98.5 (22.2) 91.4 (22.8) 0.43
BMI (kg/m2) 34.4 (7.7) 32.4 (7.3) 0.50
ASA score 0.71
1 (n) 0 1
2 (n) 6 9
3 (n) 4 10
Length of stay (days) 3.30 (1.06) 2.90 (0.31) 0.25
2 (n) 1 2
3 (n) 7 18
4 (n) 1 0
6 (n) 1 0
VTE, days from surgery (n) \0.001
1 day 4 0
2 day 6 0
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Controls
Fig. 2 Blood cell counts and the NLR in the cases and controls prior
to (Pre) and one and two days following (1-d, 2-d) TKA. a Neutrophil
counts were significantly increased on 1-d in both groups (bar,
p = 0.008 vs Pre). Neutrophil counts were not significantly different
between the cases and control (p = 0.22). b Lymphocyte counts were
significantly decreased on 1-d in both groups (bar, p = 0.008 vs Pre).
Lymphocyte counts were not significantly different between groups
(p = 0.32). c The NLRs were significantly increased in both groups
on 1-d (cases and controls, *p\ 0.001 vs Pre) and 2-d (bar, p B 0.01
vs Pre). The NLR on 1-d was significantly increased ($p = 0.002) in
the cases compared to the controls. Data are presented as mean (SD)
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additional costs. In this study, we provide the first evidence
that a more invasive knee arthroplasty procedure with an
inherently greater risk of sustaining VTE had a more pro-
nounced increase in NLR after surgery. Additionally, the
NLR after TKA predicted the subsequent occurrence of
VTE prior to hospital discharge. This latter finding sug-
gests that the NLR could serve as an inpatient monitoring
tool to assess the risk of VTE. However, considering its
uniqueness, future research is needed to confirm or refute
the present results and to establish the NLR value that
demarcates an increased risk for a VTE.
Previous studies found that an NLR [4.5 predicted
coronary heart disease mortality in patients without coro-
nary heart disease [20], while an NLR[4.7 predicted death
or myocardial infarction in patients initially assessed for
coronary artery disease [14]. In patients screened for or
diagnosed with PE, the optimum NLR cut-off value for
predicting 30-day mortality was 9.2 [9]. Although the
optimum NLR cut-off value provided by Kayrak and col-
leagues [9] is double the value related to coronary heart
disease mortality or myocardial infarction [14, 20], it is
similar to the value reported here. However, the NLR that
predicted VTE after TKA is an acutely elevated value while
the values previously reported in other patient populations
(i.e., non-orthopedic) are presumably chronic. Clearly,
additional research delineating the condition-specific NLR
that predicts clinical outcomes and the prognostic role of
acute NLR fluctuations on VTE is warranted.
Another unique finding of the present investigation was
the exaggerated increase in the NLR following TKA
compared to UKA. The exaggerated increase in the NLR
was mediated by the dramatic and more severe presence of
lymphopenia following TKA. An increase in the NLR and
lymphopenia are predictive of cardiovascular events, such
as acute myocardial infarction (AMI), VTE, and overall
mortality in cardiac patients [10–14]. Despite the use of
thromboprophylaxis, the risk of AMI (*0.4 %), VTE
(*1.1 %), and major bleeding (*0.5 %) after TKA sub-
stantially increase within 90 days of surgery [3, 5, 21].
Extrapolating from TKA data, evidence suggests that UKA
results in fewer complications in terms of DVT [4, 7, 8].
Although the percentage of TKA and UKA patients
affected by such devastating cadiovascular ailments is low,
these are impactful consequences and further research
investigating the prognostic role of the NLR on such life-
changing events after knee arthroplasty is warranted.
Although the present study provides novel results, there
are a few limitations worthy of discussion. First, in Study 2,
computed tomography and ultrasound were not performed
in the asymptomatic control group. Therefore, it is unknown
if the control group had silent DVT or PE. In line with this
limitation, data extraction and analysis were limited to
perioperative outcomes and it is unknown if any of the
controls developed VTE following discharge. Second, Study
1 consisted of a small sample size; however, this was
expected when considering the infrequency of a VTE. Third,
in Study 2, 39 % of the subjects underwent UKA and the
delineation of performing UKA was determined by a single
orthopedic surgeon with a predefined standard of care
screening protocol. This approach strengthens the interpre-
tation between patients with contrasting knee abnormalities,
but it constrains the broad application of these findings to
other studies conducted in patients who underwent TKA
who could have been candidates for UKA. Finally, although
the NLR difference between UKA and TKA groups is likely
the result of the surgical procedures, it would be remiss to
ignore the underlying pathological differences between
groups prior to arthroplasty. Future research is also needed
to identify if the type of prosthesis, as well as different types
of anticoagulant medications, impact the assessment of the
NLR on VTE following knee arthroplasty.
Despite low rates (*1–3 %), the absolute number of
patients who will sustain VTEs is anticipated to increase
with the expected continuous growth in the number of
TKA procedures performed annually. Thus, developing a
matrix that improves prognostic potential could alter
patient treatment strategies and further minimize morbidity
and mortality rates following knee arthroplasty. In this
study, the NLR increase was exacerbated following a more
invasive knee arthroplasty procedure (i.e., TKA) charac-
terized by an increased risk of VTE. Moreover, the NLR
following TKA predicted VTE prior to patient discharge.
Based on these findings, we conclude that NLR increase
could serve as a matrix for monitoring the susceptibility of
developing VTEs after knee arthroplasty and prior to
hospital discharge. Confirmation of the preliminary data
reported here is essential and could be paramount in
guiding the physician’s treatment methods during inpatient
care following knee arthroplasty.
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